We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
-$248M
Cap. Flow
-$400M
Cap. Flow %
-32.99%
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223

Top Buys

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$16.2M
2
ADPT icon
Adaptive Biotechnologies
ADPT
+$15.8M
3
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
+$12.7M
4
NBL
Noble Energy, Inc.
NBL
+$11.9M
5
SLP icon
Simulations Plus
SLP
+$10.6M

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$16M
2
BLUE
bluebird bio
BLUE
+$12.2M
3
BHP icon
BHP
BHP
+$10.7M
4
ALLO icon
Allogene Therapeutics
ALLO
+$8.56M
5
WTW icon
Willis Towers Watson
WTW
+$6.59M

Sector Composition

Rank Sector Weight
1 Healthcare 13.03%
2 Technology 7.51%
3 Consumer Discretionary 5.23%
4 Financials 5.2%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APD icon
601
PUT
Air Products & Chemicals
APD
$66.3B
– –
-1,300
Closed -$314K
AUPH icon
602
Aurinia Pharmaceuticals
AUPH
$1.97B
– –
-50,000
Closed -$813K
AVY icon
603
Avery Dennison
AVY
$12.3B
– –
-2,500
Closed -$285K
BA icon
604
CALL
Boeing
BA
$165B
– –
-12,800
Closed -$2.35M
BA icon
605
Boeing
BA
$165B
– –
-5,003
Closed -$853K
BALL icon
606
Ball Corp
BALL
$17B
– –
-48,500
Closed -$3.37M
BATRK icon
607
Atlanta Braves Holdings Series B
BATRK
$3.23B
– –
-23,556
Closed -$465K
BCRX icon
608
BioCryst Pharmaceuticals
BCRX
$2.37B
– –
-150,000
Closed -$714K
BEN icon
609
PUT
Franklin Resources
BEN
$16.9B
– –
-11,600
Closed -$243K
BG icon
610
Bunge Global
BG
$23.6B
– –
-49,000
Closed -$2.02M
BIIB icon
611
PUT
Biogen
BIIB
$29.9B
– –
-1,100
Closed -$294K
BKNG icon
612
Booking.com
BKNG
$138B
– –
-6,550
Closed -$460K
BLUE
613
DELISTED
bluebird bio
BLUE
– –
-15,440
Closed -$12.2M
BMRN icon
614
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-30,700
Closed -$3.79M
BSX icon
615
Boston Scientific
BSX
$65.8B
– –
-65,700
Closed -$2.53M
CAT icon
616
CALL
Caterpillar
CAT
$409B
– –
-9,700
Closed -$1.22M
CAT icon
617
Caterpillar
CAT
$409B
– –
-3,003
Closed -$422K
CB icon
618
CALL
Chubb
CB
$140B
– –
-2,000
Closed -$253K
CDNS icon
619
CALL
Cadence Design Systems
CDNS
$90B
– –
-3,000
Closed -$288K
CFG icon
620
PUT
Citizens Financial Group
CFG
$30.4B
– –
-10,000
Closed -$248K
CHTR icon
621
CALL
Charter Communications
CHTR
$14.7B
– –
-1,700
Closed -$867K
CNNE icon
622
Cannae Holdings
CNNE
$647M
– –
-30,000
Closed -$1.23M
COF icon
623
PUT
Capital One
COF
$124B
– –
-3,300
Closed -$206K
COST icon
624
Costco
COST
$415B
– –
-884
Closed -$297K
CRM icon
625
CALL
Salesforce
CRM
$134B
– –
-1,100
Closed -$206K
23 24
25
26 27

Similar funds

AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Maven Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.

  • Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
  • Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
  • Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
  • Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
  • Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
  • Maven Securities opened 297 new positions and closed 223 in Q3 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.

Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.